Permanent pleural catheter (PPC) for malignant pleural effusion (PE) in advanced non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Martinez Kareaga, M. [1 ]
Urbieta-Macazaga, N. [2 ]
Sanchez-Vieco, C. [3 ]
Tomas-Lopez, L. [3 ]
Intxaurbe-Etxebarria, I. [1 ]
Mareque, B. [1 ]
Torrego, N. [1 ]
Narro, A. [1 ]
Punti, L. [1 ]
Guillen, I. [1 ]
机构：
[1] Hosp Txagorritxu, Med Oncol, Vitoria, Spain
[2] Inst Invest Sanitaria Biodonostia, San Sebastian, Spain
[3] Hosp Txagorritxu, Pneumol, Vitoria, Spain
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
175P
引用
收藏
页码：63 / 63
页数：1
相关论文
共 50 条
  • [21] Molecular Profiling of Malignant Pleural Effusion in Metastatic Non-Small Cell Lung Carcinoma
    Carter, Jamal H.
    Miller, James A.
    Maleki, Zahra
    LABORATORY INVESTIGATION, 2016, 96 : 94A - 94A
  • [22] The prognostic significance of malignant pleural effusion at the time of thoracotomy in patients with non-small cell lung cancer
    Fukuse, T
    Hirata, T
    Tanaka, F
    Wada, H
    LUNG CANCER, 2001, 34 (01) : 75 - 81
  • [23] The role of VEGF in the diagnosis and treatment of malignant pleural effusion in patients with non-small cell lung cancer
    Chen, Yao
    Mathy, Nicholas W.
    Lu, Hongda
    MOLECULAR MEDICINE REPORTS, 2018, 17 (06) : 8019 - 8030
  • [24] The diagnostic value of apolipoprotein E in malignant pleural effusion associated with non-small cell lung cancer
    Wang, Yumin
    Chen, Zengqiang
    Chen, Jie
    Pan, Jingye
    Zhang, Wenhui
    Pan, Qinshi
    Ding, Hongyan
    Lin, Xiaomei
    Wen, Xiushu
    Li, Yangyang
    Meng, Qing H.
    CLINICA CHIMICA ACTA, 2013, 421 : 230 - 235
  • [25] Molecular Profiling of Malignant Pleural Effusion in Metastatic Non-Small Cell Lung Carcinoma
    Carter, Jamal H.
    Miller, James A.
    Maleki, Zahra
    MODERN PATHOLOGY, 2016, 29 : 94A - 94A
  • [26] On the identification of biomarkers for non-small cell lung cancer in serum and pleural effusion
    Rodriguez-Pineiro, A. M.
    Blanco-Prieto, S.
    Sanchez-Otero, N.
    Rodriguez-Berrocal, F. J.
    Paez de la Cadena, M.
    JOURNAL OF PROTEOMICS, 2010, 73 (08) : 1511 - 1522
  • [27] Pharmacogenomic study of docetaxel and cisplatin in patients with non-small cell lung cancer (NSCLC) stages IIIb (with malignant pleural effusion) and IV
    de las Peñas, R
    Camps, C
    Lopez-Vivanco, G
    Alonso, G
    Provencio, M
    Gonzalez-Larriba, J
    Artal, A
    Gomez, RG
    Viñolas, N
    Rosell, R
    LUNG CANCER, 2005, 49 : S37 - S37
  • [28] Prognostic value of pleural effusion in patients with non-small cell lung cancer
    Sugiura, S
    Ando, Y
    Minami, H
    Ando, M
    Sakai, S
    Shimokata, K
    CLINICAL CANCER RESEARCH, 1997, 3 (01) : 47 - 50
  • [29] Diagnostic value of pleural effusion Krebs von den Lungen-6 in malignant pleural effusion of patients with non-small cell lung cancer
    Wang, Junjun
    Ling, Liqun
    Chen, Shuhui
    Chou, Lunan
    Wang, Yumin
    Hu, Lijuan
    LABORATORY MEDICINE, 2024, 55 (03) : 271 - 276
  • [30] Pleural effusion as a significant prognostic factor in non-small cell lung cancer
    Naito, T
    Satoh, H
    Ishikawa, H
    Yamashita, YT
    Kamma, H
    Takahashi, H
    Ohtsuka, M
    Hasegawa, S
    ANTICANCER RESEARCH, 1997, 17 (6D) : 4743 - 4746
12345